Awarded
131 | Mesalazin Tabletten magensaftresistent [1]
- Buyer
- IKK classic
- Winners
- Dr. Falk Pharma GmbH
- Contract value
- €781,708
- Bids received
- 2
- Published
- 27 Jul 2026
- Awarded
- 8 Jul 2026
- Contract start
- 1 Jan 2027
- Contract end
- 31 Dec 2028stated
- Region
- Sachsen (DED21)